HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of cicletanine in the left circumflex coronary artery occlusion-reperfusion canine model of sudden death: analysis of 107 experiments using Cox's proportional hazards model.

Abstract
Multivariate analysis of survival using Cox's proportional hazards model demonstrates that several clinically measurable covariates are determinants of life-threatening arrhythmias following left circumflex coronary artery occlusion-reperfusion in 107 dogs. These are heart rate, ST segment elevation and mean aortic pressure immediately (3 min) following occlusion, and the presence of early (0-10 min) post-occlusion sustained ventricular tachycardia. The risk of occlusion-reperfusion ventricular fibrillation was determined according to Cox's solution based on ST segment elevation, thus enabling quantification of the role of cicletanine. Since cicletanine-treated dogs had reduced mean ST segment elevation at 3 min post-occlusion, lower incidence of early post-occlusion (0-10 min) sustained ventricular tachycardia, and increased endogenous production of prostacyclin, and the latter was inversely correlated with the level of ST segment elevation, it is concluded that such favourable effects on the ischaemic myocardium were contributory to the improved outcome in these experiments. These effects on the ischaemic myocardium obtained in spite of a hypotensive action in the experimental setting might be regarded as desirable and it is therefore suggested that they should be further investigated by pharmacodynamic studies in human subjects.
AuthorsR Jouve, P E Puddu, F Langlet, M Lanti, J C Guillen, P H Rolland, A Serradimigni
JournalDrugs under experimental and clinical research (Drugs Exp Clin Res) Vol. 14 Issue 2-3 Pg. 167-79 ( 1988) ISSN: 0378-6501 [Print] Switzerland
PMID3416721 (Publication Type: Journal Article)
Chemical References
  • Antihypertensive Agents
  • Diuretics
  • Pyridines
  • 6-Ketoprostaglandin F1 alpha
  • cicletanine
Topics
  • 6-Ketoprostaglandin F1 alpha (blood)
  • Animals
  • Antihypertensive Agents (therapeutic use)
  • Arrhythmias, Cardiac (etiology, prevention & control)
  • Blood Pressure
  • Coronary Disease (drug therapy, physiopathology)
  • Death, Sudden (etiology)
  • Diuretics (therapeutic use)
  • Dogs
  • Electrocardiography
  • Female
  • Heart Rate
  • Heart Ventricles
  • Male
  • Perfusion
  • Pyridines
  • Statistics as Topic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: